Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Verified Market Research | PRODUCT CODE: 1737087

Cover Image

PUBLISHER: Verified Market Research | PRODUCT CODE: 1737087

Global Healthcare Logistics Market Size By Service (Pharmaceutical Products, Medical Devices), By Product Type (Transportation, Warehousing), By Geographic Scope And Forecast

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF & Excel (5 User License)
USD 4850
PDF & Excel (Enterprise User License)
USD 7550

Add to Cart

Healthcare Logistics Market Size And Forecast

Healthcare Logistics Market size was valued at USD 84.88 Billion in 2024 and is projected to reach USD 179.31 Billion by 2032, growing at a CAGR of 9.68% from 2026 to 2032.

Healthcare logistics is a complicated system of planning, managing, and coordinating the movement of medical supplies, equipment, medications, organs, tissues, and even individuals to the appropriate location, time, and condition. Healthcare logistics, unlike conventional logistics, deals with life-critical products that necessitate particular handling and exact delivery times.

This particular field can be divided into three stages: the first mile, the middle mile, and the final mile. The first mile entails transporting medicinal items from manufacturers to distribution sites. The middle mile focuses on delivering these goods to hospitals, clinics, and pharmacies. Finally, the last mile guarantees that medications and equipment are delivered directly to patients, as needed.

Efficient healthcare logistics are critical to guaranteeing patient safety and well-being. It ensures that hospitals and clinics have enough supplies to treat patients efficiently. The timely delivery of medications, particularly those required for critical care, might be the difference between life and death. Additionally, temperature-sensitive medications and vaccines must be stored and transported properly to maintain their potency.

Beyond these essential functions, healthcare logistics is critical for research and development. It makes it easier to move clinical trial materials and biological samples, which speeds up medical advances. Furthermore, robust logistical systems are vital for handling blood banks, organ donation programs, and emergency response measures.

Global Healthcare Logistics Market Dynamics

The key market dynamics that are shaping the global healthcare logistics market include:

Key Market Drivers:

Rising Demand for Pharmaceuticals and Medical Devices: Several factors contribute to the globally pharmaceutical and medical device sectors' growth. An aging population with increasing healthcare needs, combined with the rise in chronic diseases, is driving up demand for drugs and modern medical equipment. Furthermore, advances in medical research & development are resulting in the introduction of novel medications and technologies, which is driving market expansion.

Technological Advancements: The combination of advanced technologies such as artificial intelligence (AI), blockchain, and the Internet of Things (IoT) is transforming healthcare logistics. Artificial intelligence-powered solutions can improve inventory management, forecast demand variations, and streamline delivery routes. Blockchain technology improves transparency and traceability throughout the supply chain, ensuring product authenticity and reducing counterfeiting.

Focus on Cost Efficiency and Operational Optimization: Healthcare providers and pharmaceutical companies face pressure to save costs while maintaining excellent service levels. Optimizing logistics operations saves money by improving inventory management, reducing waste, and providing effective transportation options.

Strategic Partnerships and Collaborations: Logistics and healthcare firms are increasingly forming strategic partnerships and collaborations. These alliances use third-party suppliers' logistical experience to increase supply chain resilience, efficiency, and market response.

Key Challenges:

Ensure Product Integrity and Maintain Cold Chain Management: A substantial percentage of the healthcare logistics market is concerned with temperature-sensitive products such as vaccines, blood products, medications, and biological samples. Even modest temperature fluctuations can have an impact on the effectiveness and usefulness of these medications, potentially causing negative health repercussions for patients. Maintaining a stable and ideal temperature across the supply chain, from manufacture to point-of-care delivery, is still a substantial challenges.

Data Security and Privacy Concerns: Healthcare logistics entails dealing with sensitive patient data such as medicines, medical records, and insurance information. Cybersecurity threats are an ongoing worry for the sector, and data breaches can have disastrous effects. Investing in strong cybersecurity safeguards, providing employee training on data protection procedures, and adhering to tight data privacy legislation is essential for protecting sensitive information.

Managing the "Last Mile" Challenge: The "last mile," or delivering medical supplies directly to patients' homes or care facilities, provides a unique set of obstacles for healthcare logistics providers. Geographic dispersion, road congestion, and diverse patient needs all have a substantial impact on delivery times and costs. Developing creative last-mile delivery alternatives, such as using drones or cooperating with local delivery firms, can help to overcome these issues.

Labor Shortages and Rising Operational Costs: The healthcare logistics business, like many others, is experiencing a serious manpower shortage. Finding qualified individuals with the necessary experience to handle delicate medical items might be difficult. This scarcity may cause delays, inefficiencies, and errors in the supply chain.

Key Trends:

Technology Integration: Advanced technologies such as the Internet of Things (IoT), blockchain, and artificial intelligence (AI) are rapidly being used in healthcare logistics to improve supply chain efficiency, transparency, and security. These technologies offer real-time tracking of pharmaceuticals and medical devices, resulting in improved inventory management and a reduced risk of counterfeit products.

Cold Chain Logistics: As the need for temperature-sensitive medical products such as biopharmaceuticals and vaccines grows, so does the need for advanced cold chain logistics solutions. This comprises specialized storage and transportation facilities outfitted with temperature-monitoring systems to ensure the safety of sensitive healthcare products from manufacturing to delivery.

Regulatory Compliance and Quality Assurance: Stringent regulatory regulations, particularly in pharmaceutical logistics, continue to motivate investments in compliance and quality assurance procedures. Companies are investing in advanced tracking and tracing technologies to ensure compliance with requirements such as Good Distribution Practices (GDP) and the Drug Supply Chain Security Act.

Sustainability Initiatives: Environmental sustainability has become a top priority for healthcare logistics providers. Throughout the supply chain, there is an increasing emphasis on lowering carbon emissions, eliminating waste, and optimizing resource use. Initiatives include the use of environmentally friendly packaging materials, energy-efficient modes of transportation, and recycling programs.

Global Healthcare Logistics Market Regional Analysis

Here is a more detailed regional analysis of the global healthcare logistics market:

North America:

North America is the largest global healthcare logistics market shareholder and is expected to grow at a CAGR of 7.75% over the forecast period. As the region's senior population grows, so does the incidence of chronic diseases, creating a demand for modern healthcare products and services, as well as improved medical help, to effectively treat the growing number of chronic disease patients.

As a result, there is a higher demand in this region for safe and secure transportation of drugs, medical equipment, and devices. According to a 2017 WTO assessment, the United States is the world's second-largest exporter of medical products, with reported exports totaling USD 116 billion.

The United States is also the world's second-largest ventilator exporter and third-largest exporter of personal protection equipment. The high tolerance and open-mindedness of North American citizens has supported healthcare institutions in creating and implementing an abundance of novel healthcare supply chain technology.

Europe:

Europe is expected to have a CAGR of 7.33% throughout the projection period. Current healthcare operations in Europe include value-based care, cost and margin issues, and increasing regulatory and compliance requirements.

These factors encourage healthcare manufacturers to adjust their supply chain operations in order to remain competitive in the logistics market and continue to assist healthcare providers by prioritizing patients.

Within the European medical device sector, there are two primary markets: mature (Western Europe) and emerging (East Europe). To meet Europe's demand for medical devices and pharmaceuticals, producers and logistics providers must supply low-cost logistical services.

Because of the gravity of the COVID situation, the European healthcare industry is working around the clock to assure a steady supply of necessary pharmaceuticals, medical supplies, and protective equipment. These rules have an immediate and severe influence on internationally connected supply chains, which drives regional market expansion.

Global Healthcare Logistics Market: Segmentation Analysis

The Global Healthcare Logistics Market is Segmented on the basis of Service, and Product Type And Geography.

Healthcare Logistics Market, By Service

  • Pharmaceutical Products
  • Medical Devices

Based on Service, the market is bifurcated into Pharmaceutical Products, and Medical Devices. The pharmaceutical products segment is currently dominating the Healthcare Logistics Market. It is expected to have the largest share throughout the forecast period due to the huge volume and value of pharmaceuticals shipped internationally. However, the medical device market is expected to be the fastest-growing segment. This expansion is linked to rising demand for complicated medical devices and increased use of minimally invasive procedures.

Healthcare Logistics Market, By Product Type

  • Transportation
  • Warehousing

Based on Product Type, the market is fragmented into Transportation and Warehousing. Transportation is currently the most dominant segment. This is due to the vital transportation of medical supplies, drugs, and equipment that must be delivered on time and often saves lives. Efficient transportation ensures that these products reach healthcare professionals rapidly. Warehousing is the fastest-growing segment. This growth is being driven by the increased use of complicated biological medications and the growing necessity for temperature-controlled storage. Warehousing businesses are creating specialized facilities to suit these rigorous standards.

Healthcare Logistics Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
  • On the basis of Geography, the Global Healthcare Logistics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America currently dominates the market due to its strong pharmaceutical and biopharmaceutical sectors and high healthcare spending. They maintain a consistent growth rate. Europe has a sizable stake, with an emphasis on innovative technologies and regulations. Growth is likely to remain constant.

Key Players

The "Global Healthcare Logistics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Deutsche Post DHL, Kuehne + Nagel, UPS (Marken), DB Group, FedEx, Air Canada, AmerisourceBergen Corp., CEVA Logistics AG, Continental Cargo OU, United Parcel Service Inc, Emerald Freight Express, Cavalier Logistics Management II, Inc., Alloga, KERRY LOGISTICS NETWORK LIMITED, and NIPPON EXPRESS CO., LTD., Adherium, Propeller Health, Cohero Health Inc., GlaxoSmithKline, AstraZeneca plc, Novartis AG, 3M Company, Teva Pharmaceuticals, Vectura Group, Cognita Labs, Llc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Healthcare Logistics Market Recent Developments
  • In November 2022, Cardinal Health announced the debut of VelocareTM, a supply chain network and last-mile fulfillment solution capable of delivering necessary materials and services required for hospital-level care to patients' homes in one to two hours.
  • In August 2022, United Parcel Service Inc announced that it will buy Bomi Group, an Italian healthcare logistics company, to improve its ability to transport drugs that require cold storage.
Product Code: 50205

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL HEALTHCARE LOGISTICS MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Healthcare Logistics Market Geographical Analysis (CAGR %)
  • 3.6 Global Healthcare Logistics Market, By Product Type (USD Million)
  • 3.7 Global Healthcare Logistics Market, By Service (USD Million)
  • 3.8 Future Market Opportunities
  • 3.9 Global Market Split
  • 3.10 Product Life Line

4 GLOBAL HEALTHCARE LOGISTICS MARKET OUTLOOK

  • 4.1 Global Healthcare Logistics Evolution
  • 4.2 Drivers
    • 4.2.1 Driver1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL HEALTHCARE LOGISTICS MARKET, BY PRODUCT TYPE

  • 5.1 Overview
  • 5.2 Transportation
  • 5.3 Warehousing

6 GLOBAL HEALTHCARE LOGISTICS MARKET, BY SERVICE

  • 6.1 Overview
  • 6.2 Pharmaceutical Products
  • 6.3 Medical devices

7 GLOBAL HEALTHCARE LOGISTICS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Argentina
    • 7.5.3 Rest of Latin America
  • 7.6 Middle-East and Africa
    • 7.6.1 UAE
    • 7.6.2 Saudi Arabia
    • 7.6.3 South Africa
    • 7.6.4 Rest of Middle-East and Africa

8 GLOBAL HEALTHCARE LOGISTICS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Developments
  • 8.4 Company Regional Footprint
  • 8.5 Company Industry Footprint
  • 8.6 ACE Matrix

9 COMPANY PROFILES

  • 9.1 Deutsche Post DHL
    • 9.1.1 Company Overview
    • 9.1.2 Company Insights
    • 9.1.3 Product Benchmarking
    • 9.1.4 Key Development
    • 9.1.5 Winning Imperatives
    • 9.1.6 Current Focus & Strategies
    • 9.1.7 Threat from Competition
    • 9.1.8 SWOT Analysis
  • 9.2 Kuehne + Nagel
    • 9.2.1 Company Overview
    • 9.2.2 Company Insights
    • 9.2.3 Product Benchmarking
    • 9.2.4 Key Development
    • 9.2.5 Winning Imperatives
    • 9.2.6 Current Focus & Strategies
    • 9.2.7 Threat from Competition
    • 9.2.8 SWOT Analysis
  • 9.3 UPS (Marken)
    • 9.3.1 Company Overview
    • 9.3.2 Company Insights
    • 9.3.3 Product Benchmarking
    • 9.3.4 Key Development
    • 9.3.5 Winning Imperatives
    • 9.3.6 Current Focus & Strategies
    • 9.3.7 Threat from Competition
    • 9.3.8 SWOT Analysis
  • 9.4 DB Group
    • 9.4.1 Company Overview
    • 9.4.2 Company Insights
    • 9.4.3 Product Benchmarking
    • 9.4.4 Key Development
    • 9.4.5 Winning Imperatives
    • 9.4.6 Current Focus & Strategies
    • 9.4.7 Threat from Competition
    • 9.4.8 SWOT Analysis
  • 9.5 FedEx
    • 9.5.1 Company Overview
    • 9.5.2 Company Insights
    • 9.5.3 Product Benchmarking
    • 9.5.4 Key Development
    • 9.5.5 Winning Imperatives
    • 9.5.6 Current Focus & Strategies
    • 9.5.7 Threat from Competition
    • 9.5.8 SWOT Analysis
  • 9.6 Air Canada
    • 9.6.1 Company Overview
    • 9.6.2 Company Insights
    • 9.6.3 Product Benchmarking
    • 9.6.4 Key Development
    • 9.6.5 Winning Imperatives
    • 9.6.6 Current Focus & Strategies
    • 9.6.7 Threat from Competition
    • 9.6.8 SWOT Analysis
  • 9.7 AmerisourceBergen Corp.
    • 9.7.1 Company Overview
    • 9.7.2 Company Insights
    • 9.7.3 Product Benchmarking
    • 9.7.4 Key Development
    • 9.7.5 Winning Imperatives
    • 9.7.6 Current Focus & Strategies
    • 9.7.7 Threat from Competition
    • 9.7.8 SWOT Analysis
  • 9.8 CEVA Logistics AG
    • 9.8.1 Company Overview
    • 9.8.2 Company Insights
    • 9.8.3 Product Benchmarking
    • 9.8.4 Key Development
    • 9.8.5 Winning Imperatives
    • 9.8.6 Current Focus & Strategies
    • 9.8.7 Threat from Competition
    • 9.8.8 SWOT Analysis
  • 9.9 Continental Cargo OU
    • 9.9.1 Company Overview
    • 9.9.2 Company Insights
    • 9.9.3 Product Benchmarking
    • 9.9.4 Key Development
    • 9.9.5 Winning Imperatives
    • 9.9.6 Current Focus & Strategies
    • 9.9.7 Threat from Competition
    • 9.9.8 SWOT Analysis
  • 9.10 United Parcel Service Inc
    • 9.10.1 Company Overview
    • 9.10.2 Company Insights
    • 9.10.3 Product Benchmarking
    • 9.10.4 Key Development
    • 9.10.5 Winning Imperatives
    • 9.10.6 Current Focus & Strategies
    • 9.10.7 Threat from Competition
    • 9.10.8 SWOT Analysis
  • 9.11 Emerald Freight Express
    • 9.11.1 Company Overview
    • 9.11.2 Company Insights
    • 9.11.3 Product Benchmarking
    • 9.11.4 Key Development
    • 9.11.5 Winning Imperatives
    • 9.11.6 Current Focus & Strategies
    • 9.11.7 Threat from Competition
    • 9.11.8 SWOT Analysis
  • 9.12 Cavalier Logistics Management II, Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Company Insights
    • 9.12.3 Product Benchmarking
    • 9.12.4 Key Development
    • 9.12.5 Winning Imperatives
    • 9.12.6 Current Focus & Strategies
    • 9.12.7 Threat from Competition
    • 9.12.8 SWOT Analysis
  • 9.13 Alloga
    • 9.13.1 Company Overview
    • 9.13.2 Company Insights
    • 9.13.3 Product Benchmarking
    • 9.13.4 Key Development
    • 9.13.5 Winning Imperatives
    • 9.13.6 Current Focus & Strategies
    • 9.13.7 Threat from Competition
    • 9.13.8 SWOT Analysis
  • 9.14 KERRY LOGISTICS NETWORK LIMITED
    • 9.14.1 Company Overview
    • 9.14.2 Company Insights
    • 9.14.3 Product Benchmarking
    • 9.14.4 Key Development
    • 9.14.5 Winning Imperatives
    • 9.14.6 Current Focus & Strategies
    • 9.14.7 Threat from Competition
    • 9.14.8 SWOT Analysis
  • 9.15 NIPPON EXPRESS CO., LTD.
    • 9.15.1 Company Overview
    • 9.15.2 Company Insights
    • 9.15.3 Product Benchmarking
    • 9.15.4 Key Development
    • 9.15.5 Winning Imperatives
    • 9.15.6 Current Focus & Strategies
    • 9.15.7 Threat from Competition
    • 9.15.8 SWOT Analysis
  • 9.16 Propeller Health
    • 9.16.1 Company Overview
    • 9.16.2 Company Insights
    • 9.16.3 Product Benchmarking
    • 9.16.4 Key Development
    • 9.16.5 Winning Imperatives
    • 9.16.6 Current Focus & Strategies
    • 9.16.7 Threat from Competition
    • 9.16.8 SWOT Analysis
  • 9.17 Cohero Health Inc.
    • 9.17.1 Company Overview
    • 9.17.2 Company Insights
    • 9.17.3 Product Benchmarking
    • 9.17.4 Key Development
    • 9.17.5 Winning Imperatives
    • 9.17.6 Current Focus & Strategies
    • 9.17.7 Threat from Competition
    • 9.17.8 SWOT Analysis
  • 9.18 GlaxoSmithKline
    • 9.18.1 Company Overview
    • 9.18.2 Company Insights
    • 9.18.3 Product Benchmarking
    • 9.18.4 Key Development
    • 9.18.5 Winning Imperatives
    • 9.18.6 Current Focus & Strategies
    • 9.18.7 Threat from Competition
    • 9.18.8 SWOT Analysis
  • 9.19 AstraZeneca plc
    • 9.19.1 Company Overview
    • 9.19.2 Company Insights
    • 9.19.3 Product Benchmarking
    • 9.19.4 Key Development
    • 9.19.5 Winning Imperatives
    • 9.19.6 Current Focus & Strategies
    • 9.19.7 Threat from Competition
    • 9.19.8 SWOT Analysis
  • 9.20 Novartis AG
    • 9.20.1 Company Overview
    • 9.20.2 Company Insights
    • 9.20.3 Product Benchmarking
    • 9.20.4 Key Development
    • 9.20.5 Winning Imperatives
    • 9.20.6 Current Focus & Strategies
    • 9.20.7 Threat from Competition
    • 9.20.8 SWOT Analysis
  • 9.21 3M Company
    • 9.21.1 Company Overview
    • 9.21.2 Company Insights
    • 9.21.3 Product Benchmarking
    • 9.21.4 Key Development
    • 9.21.5 Winning Imperatives
    • 9.21.6 Current Focus & Strategies
    • 9.21.7 Threat from Competition
    • 9.21.8 SWOT Analysis
  • 9.22 Teva Pharmaceuticals
    • 9.22.1 Company Overview
    • 9.22.2 Company Insights
    • 9.22.3 Product Benchmarking
    • 9.22.4 Key Development
    • 9.22.5 Winning Imperatives
    • 9.22.6 Current Focus & Strategies
    • 9.22.7 Threat from Competition
    • 9.22.8 SWOT Analysis
  • 9.23 Vectura Group
    • 9.23.1 Company Overview
    • 9.23.2 Company Insights
    • 9.23.3 Product Benchmarking
    • 9.23.4 Key Development
    • 9.23.5 Winning Imperatives
    • 9.23.6 Current Focus & Strategies
    • 9.23.7 Threat from Competition
    • 9.23.8 SWOT Analysis
  • 9.24 Cognita Labs, Llc
    • 9.24.1 Company Overview
    • 9.24.2 Company Insights
    • 9.24.3 Product Benchmarking
    • 9.24.4 Key Development
    • 9.24.5 Winning Imperatives
    • 9.24.6 Current Focus & Strategies
    • 9.24.7 Threat from Competition
    • 9.24.8 SWOT Analysis

11. VERIFIED MARKET INTELLIGENCE

  • 11.1 About Verified Market Intelligence
  • 11.2 Dynamic Data Visualization
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!